Regarding transcriptional aspects, KAT6A mRNA has been observed to be overexpressed in ER+ breast cancer, accounting for about 15% of breast cancers and a higher percentage of 22% in ER+/HER2− breast cancer [32]. This evidence concerns the gene KAT6A and breast cancer.